# Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

> **NCT07260825** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **TriHealth Inc.** · enrollment: 44 (estimated)

## Conditions studied

- Vulvodynia
- Dyspareunia
- Lichen Sclerosus of Vulva

## Interventions

- **DRUG:** Estradiol 0.01% Vag Cream
- **DRUG:** testosterone 0.1% and estradiol 0.01% vaginal cream

## Key facts

- **NCT ID:** NCT07260825
- **Lead sponsor:** TriHealth Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07260825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07260825, "Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07260825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*